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Abstract
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Chlamydia trachomatis is an obligate intracellular bacterial pathogen that causes the most
common sexually transmitted bacterial disease in the world. The bacterium has a unique biphasic
developmental cycle with a type III secretion system (T3SS) to invade host cells. Scc4 is a class I
T3SS chaperone forming a heterodimer complex with Scc1 to chaperone the essential virulence
effector, CopN. Scc4 also functions as an RNA polymerase binding protein to regulate σ66dependent transcription. Aggregation and low solubility of 6X-histidine-tagged Scc4 and the
insolubility of 6X-histidine and FLAG-tagged Scc1 expressed in Escherichia coli have hindered
the high-resolution nuclear magnetic resonance (NMR) structure determination of these proteins
and motivated the development of an on-column complex dissociation method to produce tag-free
Scc4 and soluble FLAG-tagged Scc1. By utilizing a 6X-histidine-tag on one protein, the
coexpressed Scc4-Scc1 complex was captured on nickel-charged immobilized metal affinity
chromatography resin, and the nondenaturing detergent, sodium N-lauroylsarcosine (sarkosyl),
was used to dissociate and elute the non-6X-histidine-tagged protein. Tag-free Scc4 was produced
in a higher yield and had better NMR spectral characteristics compared to 6X-histidine-tagged
Scc4, and soluble FLAG-tagged Scc1 was purified for the first time in a high yield. The backbone
structure of Scc4 after exposure to sarkosyl was validated using NMR spectroscopy, demonstrating
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the usefulness of the method to produce proteins for structural and functional studies. The
sarkosyl-assisted on-column complex dissociation method is generally applicable to protein
complexes with high affinity and is particularly useful when affinity tags alter the protein’s
biophysical properties or when coexpression is necessary for solubility.

Graphical Abstract

Author Manuscript
Author Manuscript

Chlamydia trachomatis (CT) is an obligate intracellular bacterial pathogen that causes the
most common sexually transmitted bacterial disease in the world, with over 90 million
infections each year.1,2 In the United States alone, 1.7 million people were infected in 2017
with a 6.5% increase in reported cases from 2016 to 2017.3 CT strains can be divided into at
least 18 serovars, of which serovars A–C associate with ocular infections and serovars L1–
L3 cause lymphogranuloma venereum. Serovars D–K cause sexually transmitted infections
that result in severe reproductive health complications when left untreated.4,5 Moreover, CT
infections facilitate the transmission of other sexually transmitted diseases such as HIV.6 CT
has a unique developmental cycle where infectious elementary bodies (EBs) utilize a type III
secretion system (T3SS) to introduce virulence factors into the host’s cytosol and promote
invasion into columnar epithelial cells.6,7 After internalization EBs differentiate into
reticulate bodies (RBs), which are noninfectious and metabolically active cells that rapidly
replicate. In the later stage of the developmental cycle, RBs transform into EBs, and the EBs
are released from the host cell to infect neighboring cells.6,8

Author Manuscript

Scc4 (specific chlamydia chaperone 4, formerly CT663, UniprotKB O84670) is a
bifunctional protein that plays a vital role in the developmental cycle of CT as a class 1
T3SS chaperone and a transcription factor.9−13 As a T3SS chaperone, Scc4 forms a
heterodimer complex with Scc1 (specific chlamydia chaperone 1 or CT088, UniprotKB
O84090).12,13 Scc4 and Scc1 are small cytosolic proteins that bind and stabilize the
Chlamydial outer protein N (CopN or CT089, UniprotKB O84091) prior to its secretion.
9,12,13 CopN is an effector protein secreted by the T3SS and plays an essential role in
bacterial virulence by interfering with the microtubule network.9,14,15 In addition to the
chaperone function, Scc4 acts as a transcription factor by directly binding the β subunit
(RpoB, UniprotKB P0CE09) and the primary sigma factor 66 (σ66 or RpoD, UniprotKB
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P18333) of the RNA polymerase holoenzyme.10 These interactions specifically regulate σ66dependent transcription, which controls housekeeping gene expression during the
developmental cycle of CT.10To advance our understanding of Scc4 and the mechanisms
that control its functions, a high-resolution three-dimensional structure of Scc4 is needed.
Scc4 is also a good therapeutic target to treat CT due to the essential and multiple roles of
Scc4 in CT propagation and pathogenesis. High-resolution structures of Scc4 alone and in
complex with Scc1, CopN, RpoB, and σ66 would greatly aid drug design and development
to target one or both of Scc4’s functions. Scc4 is a unique protein to Chlamydia with little
sequence similarity outside of the genus, offering the potential for highly specific
antibacterial drugs. Even though Scc4 lacks sequence homology to other proteins, it has
structural homology to several bacterial T3SS chaperones, and a good structural model can
be produced of Scc4 and its chaperone partner, Scc1.13 However, Scc4 has no sequence or
structural similarity to any known transcription factors, providing the possibility of a new
structural fold for this function. Our group has been pursuing the high-resolution structure of
Scc4 to investigate its transcription factor structure and function.

Author Manuscript

In order to determine the high-resolution structures of proteins, large quantities of pure
protein are needed in the native conformation with high solubility and low aggregation
tendency. The most common strategy to achieve these criteria is to express the recombinant
gene in Escherichia coli with a purification tag and purify the protein with the corresponding
method, such as purifying a protein with a 6X histidine-tag (His6-tag) using nickel-charged
immobilized metal affinity chromatography (Ni-IMAC).16 Purification tags can interfere
with the native structure, activity, and physical properties of a protein. The tags can also
preclude high-resolution structure determination by X-ray crystallography by interfering
with crystallization or nuclear magnetic resonance spectroscopy (NMR) by inducing
aggregation. We previously reported that an N-terminal His6-tag on Scc4 causes aggregation
and a C-terminal His6-tag or FLAG-tag on Scc1 causes insolubility.13 One strategy to
overcome the deleterious effects of affinity tags is to remove the tag by inserting a selective
protease recognition sequence between the tag and the protein of interest. This strategy
typically leaves behind a few residues from the protease recognition sequence, but a few
methods have been developed to produce tag-free proteins.17,18 One potential problem with
removing the tag is low protease activity due to the insolubility of the protein or steric
hindrance from the protein of interest. The ideal situation for a soluble protein is to express
it without a purification tag if a suitable purification method is available.

Author Manuscript

In this study, we developed a purification method to obtain tag-free proteins; specifically,
tag-free Scc4, an RNA polymerase binding protein from CT. By taking advantage of the
high-affinity between Scc4 and Scc1, the heterodimer T3SS chaperone complex was
coexpressed and immobilized on Ni-IMAC resin via a His6-tag on Scc1. The nondenaturing
detergent, sodium N-lauroylsarcosine (sarkosyl), was found to dissociate the complex
without disrupting the immobilized nickel and His6-tag interaction, allowing tag-free Scc4 to
be separated. The yield of tag-free Scc4 by way of sarkosyl-assisted on-column complex
dissociation was 6–7 times higher than His6-tagged Scc4 (His6-Scc4) using standard NiIMAC, likely due to the increased solubility of tag-free Scc4. We show that sarkosyl does
not alter the backbone structure of Scc4 and the quality of the 1H, 15N heteronuclear single
quantum coherence (HSQC) spectrum of tag-free Scc4 is better than His6-Scc4 for NMR
Biochemistry. Author manuscript; available in PMC 2020 July 02.
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structure determination. The method can also be implemented reciprocally to produce Scc1
with a C-terminal FLAG tag (Scc1-FT) using the coexpressed His6-Scc4-Scc1-FT complex.
We anticipate that this method can be applied to other proteins in tight-binding complexes to
produce tag-free proteins for structural and functional studies.

MATERIALS AND METHODS
Materials.

Author Manuscript

The recombinant expression plasmids, pA-CYCScc1-His6, pET28Scc4, and pCDFScc4,
were described previously.13 Plasmid pScc1-FT19 was kindly provided by Dr. Ken Fields
(University of Kentucky, College of Medicine, Lexington, Kentucky, USA). These plasmids
encode Scc1 with a C-terminal His6-tag that is removable with tobacco Etch virus protease
(Scc1-His6), tag-free Scc4, Scc4 with an N-terminal His6-tag (His6-Scc4), and Scc1 with a
C-terminal FLAG tag (Scc1-FT), respectively. All water used was supplied from a Millipore
Direct-Q 3 ultrapure water system. All solutions containing sodium dodecyl sulfate (SDS),
sarkosyl, and glycerol are reported as percentage mass/volume. Other reagents reported as
percentages, such as methanol, water, acetic acid, and D2O, are in units of percentage by
volume unless otherwise stated.
Protein Expression of Scc4-Scc1 Complexes and His6-Scc4.
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The Scc4-Scc1-His6 complex and His6-Scc4 were expressed in E. coli BL21-Gold (DE3)
and T7 Express lysY/IqE. coli cells, respectively, as described by Shen et al.13 15N/13Clabeled Scc4-Scc1-His6 complex and 15N-labeled His6-Scc4 were produced following the
isotopic labeling method described by Marley et al.,20 where the cells are grown in rich
medium and then exchanged into minimal medium supplemented with 15NH4Cl (15N, 99%)
and 13C-glucose (U-13C6, 99%) before induction. The minimal growth medium was M9
salts (50 mM Na2HPO4, 20 mM KH2PO4, 10 mM NaCl, 18 mM (1.0 g/L) 15NH4Cl), 2 mM
MgSO4, 0.1 mM CaCl2, 1X BME vitamins, 3.0 mM (1.0 mg/L) thiamine hydrochloride, 1X
trace metal solution,21 and 22 mM (4.0 g/L) glucose or 13C-glucose with the appropriate
antibiotics. For coexpressing the Scc4-Scc1-His6 complex from pET28Scc4 and
pACYCScc1-His6, 50 μg/mL kanamycin and 35 μg/mL chloramphenicol were used; and for
expressing His6-Scc4 from pCDFScc4, 50 μg/mL spectinomycin was used. To produce 15N/
13C-labeled protein, the bacterial cultures were first grown in LB medium until an optical
density of 0.6 at 600 nm was reached. The medium was then exchanged to minimal medium,
and the bacterial cultures were incubated at 37 °C with 250 rpm shaking for 1 h before 0.5
mM isopropyl βc1-thiogalactopyranoside (IPTG) was added. The minimal medium cultures
were incubated at 16 °C with 250 rpm shaking for 16 h. From all cultures, cells were
harvested by centrifugation at 3000g for 20 min at 4 °C and suspended in 15 mL of Tris
wash buffer (20 mM tris(hydroxymethyl)-aminomethane hydrochloride (Tris), 300 mM
NaCl, 2 mM imidazole, and 5% glycerol at pH 8.0). The cells were either stored at −80 °C
or processed for protein purification. The same expression procedures were used to produce
unlabeled and 15N/13C-labeled His6-Scc4-Scc1-FT complex using pCDFScc4 and pScc1FT in E. coli T7 Express cells with the appropriate antibiotics (50 μg/mL spectinomycin,
100 μg/mL ampicillin).
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Suspension of bacterial cell pellets (15 mL) from the expressions were prepared for lysis by
adding 2 Pierce EDTA free protease inhibitor mini tablets, 1.7 mL of 10× BugBuster protein
extraction reagent, and 0.75 μL of Benzonase nuclease. The cells were lysed using a French
pressure cell followed by centrifugation at 25 000g for 30 min at 4 °C to obtain soluble
protein in the cleared lysate. The cleared lysate containing either Scc4-Scc1-His6, His6Scc4-Scc1-FT, or His6-Scc4 was immediately loaded onto 4 mL of Ni-IMAC resin (1 cm i.d.
column) at a flow rate of 1 mL/min using a fast protein liquid chromatography system
(FPLC). The captured proteins were washed with 20 mL of Tris wash buffer and eluted with
20 mL of Tris elution buffer (20 mM Tris, 300 mM NaCl, 500 mM imidazole, and 5%
glycerol at pH 8.0) at a flow rate of 2 mL/min. The eluted proteins were detected using
absorbance at 280 nm (A280) and pooled from 1 mL fractions (typically 5–6 mL). The Tris
elution buffer was exchanged to the desired buffer using 15 mL of P4 gel (polyacrylamide
beads in a 1 cmi.d. column) at a flow rate of 0.5 mL/min with 1 mL fractions. The protein
fractions were combined based on A280 and analyzed using the Bradford protein assay
following the manufacturer’s 96-well plate instructions (Pierce Comassie Plus Assay Kit,
Thermo Fisher Scientific). The results from the Bradford protein assay are reported in the
results as mg protein or complex per L culture. Samples taken during the purification of the
proteins, including the purified proteins, were analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Sample aliquots (10 μL) were mixed with
10 μL of 2X Laemmli buffer with 5% (by volume) of β-mercaptoethanol, heated at 95 °C for
5 min, and loaded into 4–20% Tris/glycine gels. The gels were run at 120 V for 45 min in
running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3 buffer) followed by
staining with brilliant blue R-250 solution (0.1% (m/V) brilliant blue R-250 dye, 50%
methanol, 40% water, and 10% acetic acid). After destaining in 50% water, 40% methanol,
10% acetic acid, the gels were imaged using a Bio-Rad Gel Doc EZ System.
On-Column Complex Dissociation of Scc4-Scc1-His6.
Various reagents were tested to dissociate tag-free Scc4 from immobilized Scc4-Scc1-His6
complex. Purified Scc4-Scc1-His6 complex in Tris buffer (20 mM Tris, 300 mM NaCl, 5%
glycerol, pH 8.0) was loaded onto 1 mL of Ni-IMAC resin and briefly washed with Tris
buffer. In separate experiments, the dissociation of tag-free Scc4 from the immobilized
complex was tested by washing the resin with 10 mL of 6 M urea, 8 M urea, 2% SDS, or
0.5% sarkosyl in Tris buffer. Any remaining protein was eluted from the column with 10 mL
of Tris buffer with 500 mM imidazole. SDS-PAGE analysis was used to determine the
protein content in the dissociation and elution fractions.

Author Manuscript

To estimate the minimum concentration of sarkosyl needed to dissociate tag-free Scc4 from
the immobilized Scc4-Scc1-His6 complex, a gradient elution from 0–1% sarkosyl in 50 mM
sodium phosphate, 300 mM sodium chloride, pH 7.4 buffer at a flow rate of 1 mL/min over
10 min was performed using an FPLC. The dissociation of Scc4 was monitored by A280.
The minimum concentration of sarkosyl was estimated as the sarkosyl concentration
corresponding to the maximum A280 of the Scc4 elution peak.
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Tag-free Scc4 was purified by on-column dissociation of the Scc4-Scc1-His6 complex by
selective elution of Scc4 with 0.5% sarkosyl buffer followed by elution of Scc1-His6 with
500 mM imidazole buffer. Scc4-Scc1-His6 (purified or in cleared lysate) was loaded onto 4
mL (1 cm i.d. column) of Ni-IMAC resin using an FPLC and a flow rate of 1 mL/min.
Subsequent wash and elution steps used a flow rate of 2 mL/min, and the elution samples
were collected as 1 mL fractions and pooled based on A280. The immobilized complex was
washed with 20 mL of Tris wash buffer. Tag-free Scc4 was eluted with 20 mL of Tris wash
buffer containing 0.5% sarkosyl. The remaining immobilized Scc1-His6 was either eluted
with 10 mL of 500 mM imidazole elution buffer or used to purify excess tag-free Scc4 from
the lysate flow-through. For purifying excess tag-free Scc4, the immobilized Scc1-His6 was
washed with 20 mL of wash buffer to remove residual sarkosyl, the lysate flow-through was
reloaded at 1 mL/min, and tag-free Scc4 was eluted with 0.5% sarkosyl buffer. To remove
trace quantities of Scc1-His6 from the purified tag-free Scc4, the Scc4 elution was filtered
through 4 mL of fresh Ni-IMAC resin. To remove the sarkosyl from the purified tag-free
Scc4, the sample was diluted 5-fold with 50 mM sodium phosphate, pH 7.3 buffer to reduce
the sarkosyl concentration below the critical micelle concentration (cmc). The diluted
solution was then concentrated to 4 mL using a 10 kDa molecular weight cutoff centrifugal
filter, and exchanged to 50 mM sodium phosphate, pH 7.3 buffer using 15 mL of P4 gel. To
determine if the dissociation of the complex was independent of the His6-tag position, Scc1FT-His6-Scc4 (purified or in cleared lysate) was treated identically as described for sarkosylassisted on-column dissociation of the Scc4-Scc1-His6 complex. In this situation, Scc1-FT
elutes with the 0.5% sarkosyl buffer and His6-Scc4 elutes with the 500 mM imidazole buffer.
NMR Spectroscopy.

Author Manuscript

1H-15N

HSQC spectra of His6-Scc4 and tag-free Scc4 were collected to determine if the
proteins were suitable for NMR structure determination. NMR samples of Scc4 were
prepared by desalting approximately 2 mg of protein into various buffers using a P4 gel
column and concentrating to 250 μL using 10 kDa molecular weight cutoff centrifugal
filters. The samples were transferred to 5 mm D2O susceptibility matched Shigemi tubes,
and 5 μM sodium 3-(trimethylsilyl)-1-propanesulfonate (DSS) and 10% D2O were added for
chemical shift referencing and locking, respectively. The 2D 1H-15N HSQC spectra were
collected of 0.5 mM Scc4 samples on a Bruker Advance III HD 500 MHz instrument (16–64
scans, 256 increments) at 300 K (27 °C).

RESULTS AND DISCUSSION
Author Manuscript

Suitability of His6-Scc4 for NMR Structure Determination.
Since crystallographic trials of various Scc4 constructs have thus far been unsuccessful, the
suitability of His6-Scc4 for NMR structure determination was evaluated. Structure
determination by NMR requires that the protein be 13C/15N-labeled, soluble at 0.2–1 mM
concentrations, and ≥95% pure. These requirements are typically achieved by testing various
constructs of the protein; for example, altering the purification tag and optimizing the
sample buffer conditions to reach high solubility. The expression and purification of GSTScc4 (formerly GST-CT663)10 was tested, but low solubility of the protein led to low yields
Biochemistry. Author manuscript; available in PMC 2020 July 02.
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(Figure S1). His6-Scc4 was produced in 15N-supplemented minimal medium with a
moderate yield of 2–3 mg protein per L culture (Figure S2). Figure 1 shows the 2D 1H-15N
HSQC spectrum of 0.5 mM His6-Scc4 in 50 mM sodium phosphate, pH 7.3 buffer. The peak
dispersion of His6-Scc4 is good and indicates that the protein is folded, but only 75% of the
expected backbone amide (N–H) correlation peaks are visible (typically ≥90% is desirable).
The spectrum also shows heterogeneous peak intensities and broad peaks clustered in the
center of the spectrum. These features indicate that His6-Scc4 is aggregating, forming
soluble oligomers, or partially unfolding under these conditions, consistent with published
size exclusion chromatographic analysis of His6-Scc4, which shows a size dependence with
buffer conditions (dimers and trimers) and species greater than 150 kDa in phosphate buffer.
13 Other conditions were tested by varying the protein concentration, salt concentration, pH,
and buffering reagent with no better results, so a different construct of Scc4 was needed to
proceed with NMR structure determination.

Author Manuscript

Sarkosyl-Assisted on-Column Complex Dissociation of Scc4-Scc1-His6 To Produce TagFree Scc4.
Based on early experiments in our laboratory with 15N-labeled tag-free Scc4, the 1H-15N
HSQC spectrum looked promising but was dismissed due to the labor-intensive purification
of tag-free Scc4. After disappointing results with other Scc4 constructs, alternative methods
were explored to produce tag-free Scc4. It has been shown that Scc4 and Scc1-His6 express
well in E. coli and copurify as a 1:1 molar ratio complex.13 The dissociation of this complex
would provide a straightforward method to purify tag-free Scc4.

Author Manuscript
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Scc4-Scc1-His6 was captured on Ni-IMAC resin to determine whether the complex could be
dissociated using some common reagents. Dissociation of Scc1-His6 and tag-free Scc4 is
challenging due to the high affinity of the complex, which we estimate to have a dissociation
constant in the sub-nM range based on published size exclusion chromatographic data and
the 1:1 stoichiometry of the copurified complex.13 To succeed in isolating tag-free Scc4, the
reagent should only disrupt the interaction between Scc4 and Scc1-His6 and not affect the
immobilized nickel and His6-tag interaction. The Scc4-Scc1-His6 complex was produced in
high yield (12–15 mg of complex per L culture using LB medium or minimal medium) and
purified as a 1:1 molar ratio complex (Figure S3). The complex was exchanged into an
imidazole-free buffer using P4 gel and immobilized onto fresh Ni-IMAC resin. Figure 2
shows an SDS-PAGE gel of the imidazole-eluted proteins after the captured Scc4-Scc1-His6
complex was washed with 6 M urea (lane 4), 8 M urea (lane 5), 2% SDS (lane 6), and 0.5%
sarkosyl (lane 7). Urea is a common denaturing agent used for unfolding protein by direct
interaction with the protein or indirect interaction with the solvation of hydrophobic groups.
22 Surprisingly, the urea-washed samples did not fully dissociate the complex as both Scc4
and Scc1-His6 were present in the imidazole elution samples. After washing with 2% SDS
or 0.5% sarkosyl, the imidazole elution samples only contained Scc1-His6 confirming the
dissociation of the Scc4-Scc1-His6 complex. SDS and sarkosyl are negatively charged,
amphiphilic detergents, which can affect the hydrophobic interactions of proteins.23
Sarkosyl is milder than SDS,23 causing less protein denaturation, and has been used to
disrupt protein aggregates and strong protein-protein interactions without affecting the
protein’s function.24,25 For the initial tests, the protein that eluted in the wash steps (with 6
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M urea, 8 M urea, and 2% SDS) were not collected or analyzed by SDS-PAGE; however, the
0.5% sarkosyl test was repeated in order to collect both the protein eluted with sarkosyl
(Figure 2, lane 9) and the protein eluted with imidazole (Figure 2, lane 7). The SDS-PAGE
analysis of these samples shows that tag-free Scc4 cleanly and completely dissociates from
Scc1-His6 with the 0.5% sarkosyl buffer.

Author Manuscript

The minimum concentration of sarkosyl needed to disrupt the Scc4-Scc1-His6 complex was
estimated by monitoring the elution of tag-free Scc4 from the immobilized complex with a
gradient of sarkosyl concentrations (0–1% sarkosyl in 50 mM sodium phosphate, 300 mM
sodium chloride, pH 7.4 buffer over 10 mL). Tag-free Scc4 starts eluting at 3.0 mL with a
maximum A280 at 4.4 mL in the chromatogram (Figure S5). These volumes correspond to
0.30 and 0.44% sarkosyl in the running buffer. Interestingly, the cmc of sarkosyl is reported
to depend on the pH and buffer composition with a range of values in water from 0.10 to
0.28% (pH 7–8.5, 3.3–9.5 mM) and a value of 0.18% (6.2 mM) in 20 mM sodium
phosphate, pH 7 buffer (all measured by surface tension).26,27 The cmc of sarkosyl measured
by conductivity in water at pH 8.5 is reported to be 0.38% (13 mM).26 Comparing our
results to the published cmc values suggests that micelle formation is necessary to dissociate
tag-free Scc4 from the complex; although, the interpretation is limited by the unknown
effects of the buffer composition and Ni-IMAC resin on sarkosyl’s cmc. Other reports that
use sarkosyl to disrupt protein-protein interactions report concentrations from 0.1–0.5% with
different optimal concentrations for different complexes.25,28,29 A concentration of 0.5%
sarkosyl was chosen for the on-column dissociation of the Scc4-Scc1-His6 complex to
ensure efficient elution of tag-free Scc4.

Author Manuscript
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The sarkosyl-dissociation method was used to purify tag-free Scc4 and Scc1-His6 from
cleared lysate containing the coexpressed proteins. The relative amount of tag-free Scc4
expressing from pET28Scc4 and Scc1-His6 expressing from pACYCScc1-His6 in E. coli
cells is variable with Scc1-His6 being less than tag-free Scc4, likely due to the pACYC184
plasmid having a lower copy number than the pET28 plasmid. Comparing the induction of
protein expression in Figure 3, lanes 1 and 2, tag-free Scc4 is overexpressed with lower
quantities of Scc1-His6. In this situation, excess tag-free Scc4 flows through the Ni-IMAC
resin with the unbound proteins in the cleared lysate. After dissociating tag-free Scc4 from
Scc1-His6 with 0.5% sarkosyl, the Ni-IMAC-bound Scc1-His6 was used to directly capture
excess Scc4 from the lysate flow through. The immobilized Scc1-His6 is washed with Tris
wash buffer to remove any residual sarkosyl, and the lysate flow through containing excess
tag-free Scc4 is reloaded, captured, and eluted with sarkosyl buffer. The reloading of the
lysate flow-through can be done several times to purify all of the excess tag-free Scc4
(Figure S6). The yield of tag-free Scc4 is 12–15 mg of protein per L culture in LB and
minimal media, which is 6–7 times the yield of His6-Scc4 expressed alone (2–3 mg of
protein per L culture). As shown in Figure 3, lane 3, the purified tag-free Scc4 can
sometimes contain small amounts of Scc1-His6. Since this observation is not seen every
time, the coeluting Scc1-His6 likely originates from the dissociation of Scc4-Scc1-His6
tetramer13 in situations where the Ni-IMAC capacity is low. This hypothesis is based on
previous work showing Scc4-Scc1-His6 forms tetramers in Tris buffer.13 The contaminating
Scc1-His6 protein is easily removed by passing the sample through fresh Ni-IMAC resin to
obtain highly pure tag-free Scc4 (Figure 3, lane 4). Finally, Scc1-His6 can be eluted with
Biochemistry. Author manuscript; available in PMC 2020 July 02.
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500 mM imidazole buffer (Figure 3, lane 7). The eluted Scc1-His6 is pure with no traces of
tag free Scc4, demonstrating that 0.5% sarkosyl efficiently elutes tag-free Scc4. Scc1-His6
has good solubility in the Tris elution buffer with 500 mM imidazole, but the protein
precipitates as the imidazole concentration is lowered or when the buffering reagent is
changed.
Sarkosyl-Assisted on-Column Complex Dissociation with the His6-Tag Interchanged.

Author Manuscript

The His6-Scc4-Scc1-FT complex was produced to demonstrate that the sarkosyl-dissociation
method works with the His6-tag positioned on Scc4 instead of Scc1. Figure 4 shows an SDSPAGE gel of the coexpression and copurification of His6-Scc4-Scc1-FT. In contrast to the
ratio of coexpressed tag-free Scc4 and Scc1-His6, coexpression of His6-Scc4 and Scc1-FT
produced similar quantities of protein (approximately 1:1) (Figure 4, lanes 1 and 2). In the
purification shown in Figure 4, the yield was high enough to saturate the Ni-IMAC resin,
and the residual complex was present in the lysate flow-through (Figure 4, lane5) and wash
(Figure 4, lane 6) samples. The excess complex was recovered using fresh Ni-IMAC resin.
Similar to the purified Scc4-Scc1-His6 complex, the His6-Scc4-Scc1-FT complex copurifies
in a 1:1 molar ratio (Figure 4, lane 7). The overall yield of His6-Scc4-Scc1-FT is higher than
Scc4-Scc1-His6 at 20–24 mg of complex per L culture in LB medium.

Author Manuscript

To demonstrate that the sarkosyl-dissociation method works with an interchanged His6-tag,
purified His6-Scc4-Scc1-FT (Figure 5, lane 2) was captured on Ni-IMAC resin and washed
with 0.5% sarkosyl buffer. Scc1-FT eluted in 0.5% sarkosyl buffer with residual His6-Scc4
(Figure 5, lane 4). Similar to the residual elution of Scc1-His6 with tag-free Scc4, the
residual His6-Scc4 was removed by passing the sample through fresh Ni-IMAC resin (data
not shown). The remaining immobilized His6-Scc4 was eluted in 500 mM imidazole buffer
(Figure 5, lane 5). The imidazole elution sample shows complete dissociation of the
complex, but the sample also contains the typical background E. coli proteins that
nonspecifically bind Ni-IMAC.30 The background E. coli proteins are a common problem
with Ni-IMAC, but the absence of these background proteins in the sarkosyl elution of Scc1FT (Figure 5, lane 4) demonstrates an inherent advantage of the sarkosyl-dissociation
method compared to standard Ni-IMAC. Because the sarkosyl buffer does not disrupt the
interactions between the Ni-IMAC resin and the His6-tagged protein or the background E.
coli proteins, the sarkosyl-eluted tag-free or non-His6-tagged protein is free of these
background proteins.

Author Manuscript

An unanticipated advantage of the sarkosyl-dissociation method is Scc1-FT is soluble when
it is purified from the His6-Scc4-Scc1-FT complex. When Scc1-His6 and Scc1-FT are
expressed alone, the proteins are mostly insoluble (Figure S7),13 and Scc1-His6 dissociated
from the Scc4-Scc1-His6 complex was only soluble in high-imidazole Tris buffer. Even
though sarkosyl is commonly used to solubilize inclusion bodies and coaggregated proteins,
24,31,32 these methods did not solubilize Scc1-FT (expressed alone) from the lysed cell pellet
(Figure S7). In contrast, dissociated Scc1-FT was soluble in sodium phosphate or Tris buffer
(at pH 7–8) even after sarkosyl was removed. Purified His6-Scc4-Scc1-FT complex or lysate
containing the coexpressed complex can be used for on-column complex dissociation of
Scc1-FT with yields of 12–15 mg of protein per L culture in LB medium. Access to soluble
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Scc1-FT allows, for the first time, the investigation of Scc4 and Scc1 complex formation and
binding kinetics, which is currently being pursued in our laboratory.
Validation of the Tag-Free Scc4 Structure.

Author Manuscript
Author Manuscript

Because sarkosyl has the potential to disrupt the tertiary structure of Scc4, 2D 1H-15N
HSQC NMR was used to compare the backbone structures of Scc4 exposed to sarkosyl and
His6-Scc4 expressed alone and purified without sarkosyl. Two samples of Scc4 exposed to
sarkosyl are (i) tag-free Scc4 eluted in 0.5% sarkosyl buffer from the captured Scc4-Scc1His6 complex and(ii) His6-Scc4 washed with 0.5% sarkosyl to dissociate the captured His6Scc4-Scc1-FT complex. The sarkosyl-washed His6-Scc4 will be indicated with an asterisk
(His6-Scc4*) to avoid confusing it with the His6-Scc4 sample that was not exposed to
sarkosyl. Even though sarkosyl has been shown to retain the activity of some enzymes,
23−25,32 tag-free Scc4 in0.5% sarkosyl was immediately diluted to 0.1% to avoid any
negative effects on the native structure. Diluting the sarkosyl to0.1% disrupts the micelles
and allows for the removal of sarkosyl using dialysis tubing or centrifugal filters. 1D 1H
NMR was used to verify the absence of sarkosyl in the Scc4 NMR samples (data not
shown). Figure 6A shows the 1H-15N HSQC spectrum of 0.3 mM His6-Scc4* in 50 mM
sodium phosphate, 10% D2O, 50 μM DSS, pH 7.3 buffer with 64 scans using a Bruker AVIII
500 MHz. These are the same conditions used to analyze the 0.5 mM His6-Scc4 sample
shown in Figure 1. The protein concentrations of these two samples are only different
because the yield of His6-Scc4* was lower than expected for this sample preparation. To
compensate for the concentration difference, the maximum contour levels used in each
spectrum were scaled to allow for direct comparison. An overlay of the two spectra in Figure
6B shows that the peak positions and relative peak intensities are the same, indicating that
the backbone structures are the same regardless of exposure to 0.5% sarkosyl. If the
structure of His6-Scc4* changes in the presence of sarkosyl, then the effect is reversible. It is
interesting that the backbone structure of His6-Scc4* is not different from His6-Scc4
considering His6-Scc4* was originally in complex with Scc1-FT. This observation does not
exclude the possibility of a different Scc4 structure when in complex with Scc1, but it
suggests that the free form of Scc4 is independent of its origin. In the context of Scc4’s dual
functions in CT, these data suggest that the in vivo origin of free Scc4 acting as a
transcription factor could arise from the dissociation of the Scc4-Scc1 complex or
expression of Scc4.

Author Manuscript

The 1H-15N HSQC spectrum of tag-free Scc4 in Figure 7A shows that tag-free Scc4 is a
good candidate for NMR structure determination. Comparing the spectra of tag-free Scc4
and His6-Scc4 (overlaid in Figure 7B) shows that most of the peak positions are the same,
indicating that the backbone structure of tag-free Scc4 is similar to His6-Scc4 despite being
exposed to sarkosyl. Some peak positions are expected to be different due to the presence of
the His6-tag, which can alter the chemical shifts of local nuclei. There are no apparent
effects from sarkosyl on the backbone structure of tag-free Scc4. The spectrum of tag-free
Scc4 has better features than the His6-Scc4 spectrum. In Figure 7B, the contour level is
adjusted by a factor of 2 for tag-free Scc4 to compensate for the 4-fold difference in the
number of signal-averaged scans (16 scans for tag-free Scc4 and 64 scans for His6-Scc4).
This adjustment allows a direct comparison of the signals. The sharp peaks in both spectra,
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corresponding to the side-chain amide groups and the C-terminal amide, have similar signalto-noise ratios, but the broad peaks from other backbone amide groups in the His6-Scc4
spectrum are sharper with higher intensity in the tag-free Scc4 spectrum (Figure 7C). The
more uniform peak intensities of tag-free Scc4 increases the peak-to-peak resolution and
reduces the number of scans needed for signal averaging, which is especially important to
minimize the instrument time used to collect data for high-resolution structure
determination. Over 90% of the expected backbone amide (N–H) correlation peaks are
visible for tag-free Scc4, compared to only 75% for His6-Scc4, so determining the NMR
structure of tag-free Scc4 is feasible and currently in progress.

CONCLUSIONS
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A method to produce tag-free Scc4, an RNA polymerase binding protein from CT, was
developed by dissociating the E. coli-expressed CT T3SS chaperone complex, Scc4-Scc1,
with sarkosyl while immobilized on Ni-IMAC resin. Developing this method specifically for
Scc4 was important because affinity purification tags caused adverse effects that were
problematic for NMR structural studies. A direct-capture affinity method using immobilized
Scc1-His6 or Scc1-FT to capture tag-free Scc4 was not possible because these Scc1constructs are not soluble when expressed alone. Scc1-His6 is soluble when coexpressed
with tag-free Scc4, and the immobilized Scc1-His6 from the complex can be used to directly
capture excess tag-free Scc4 from the lysate. Using sarkosyl as a nondenaturing detergent,
tag-free Scc4 was produced in higher yield and with better characteristics for NMR structure
determination compared to His6-Scc4. The sarkosyl did not alter the backbone structure of
Scc4 or interfere with the nickel-His6-tag interaction. The method was also successful in
purifying Scc1-FT by interchanging the His6-tag to Scc4. In our study, Scc1-FT expressed
alone could not be recovered, even with sarkosyl buffer, but soluble Scc1-FT was produced
using the coexpressed complex, His6-Scc4-Scc1-FT, and the sarkosyl-dissociation method.

Author Manuscript

The sarkosyl-dissociation method can be applied to other protein complexes based on the
reported uses of sarkosyl for protein recovery and purification23−29,31,32 and the results
presented herein. The method is limited to protein complexes with high-affinity such that the
immobilized complexes can be washed without leaching the protein of interest. The method
is especially useful when the protein of interest is insoluble without its partner or when
affinity tags and protease cleavage sites lead to undesirable properties. In addition to the
primary advantage of producing tag-free proteins, dissociating the complex and eluting the
protein of interest with sarkosyl has an additional advantage, compared to eluting His6tagged proteins with imidazole, because the contaminating E. coli proteins with affinity for
Ni-IMAC resin do not elute with sarkosyl and the tag-free protein. Alternating the position
of the His6-tag allows different proteins in the complex to be purified as demonstrated with
the Scc4-Scc1-His6 and His6-Scc4-Scc1-FT complexes. This feature allows each protein in a
complex to be produced tag-free (or with a different tag), which offers the potential to
assemble a completely tag-free complex. The dissociation method can also be used to make
asymmetrically labeled samples, where each subunit has a different isotope pattern; these
labeling schemes are important for studying quaternary structures by NMR.33 We are
currently applying the sarkosyl-dissociation method to produce asymmetrically labeled
Scc4-Scc1 samples for NMR structure determination of the complex.
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T3SS

type III secretion system

NMR

nuclear magnetic resonance

sarkosyl

sodium N-lauroylsarcosine

SDS

sodium dodecyl sulfate

CT

Chlamydia trachomatis

EBs

elementary bodies

RBs

reticulate bodies

His6-tag

6X histidine-tag

Ni-IMAC

nickel-charged immobilized metal affinity chromatography

HSQC

heteronuclear single quantum coherence

IPTG

isopropyl β-D-1-thiogalactopyranoside

Tris

tris-(hydroxymethyl)aminomethane hydrochloride

FPLC

fast protein liquid chromatography system

A280

absorbance at 280 nm

SDS-PAGE

sodium dodecyl sulfate-polyacrylamide gel electrophoresis

cmc

critical micelle concentration

DSS

sodium3-(trimethylsilyl)-1-propanesulfonate
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Figure 1.
1H-15N

HSQC spectrum of 0.5 mM 15N-labeled His6-Scc4 with 64 scans.

Author Manuscript
Biochemistry. Author manuscript; available in PMC 2020 July 02.

Ukwaththage et al.

Page 16

Author Manuscript
Author Manuscript

Figure 2.
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Various reagents were tested to dissociate the Scc4-Scc1-His6 complex while it was
immobilized on Ni-IMAC resin. Lane numbers are labeled along the bottom. Lane 1 is BioRad Precision Plus protein standards with the molecular weights listed to the left in kDa.
Lanes 2 and 3 are positive control samples of purified His6-Scc4 and Scc4-Scc1-His6
complex (Scc4 is 14.7 kDa, and Scc1-His6 is 18.8 kDa). Immobilized Scc4-Scc1-His6 was
washed with various reagents, and the remaining proteins were eluted with 500 mM
imidazole buffer. Lanes 4–7 show the imidazole elution samples of immobilized Scc4-Scc1His6 washed with 6 M urea, 8 M urea, 2% SDS, and 0.5% sarkosyl, respectively. Lane 8 is
Fisher BioReagents EZ-Run Rec prestained protein ladder with the molecular weights listed
to the left in kDa. Lane 9 is the protein eluted with 0.5% sarkosyl buffer (counterpart to the
imidazole elution sample in lane 7) from the immobilized Scc4-Scc1-His6 complex.
Individual gel images were aligned using the protein ladders as references, and some ladders
were removed to improve visualization and comparison. Protein loading was not
standardized. The complete gels can be viewed in Figure S4.
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Figure 3.
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SDS-PAGE analysis of the expression and purification of tag-free Scc4 from the Scc4-Scc1His6 complex. Lane numbers are labeled along the bottom. Lanes 1 and 2 are the whole cell
lysate before and after induction with IPTG showing higher levels of tag-free Scc4
compared to Scc1-His6. Asterisks mark tag-free Scc4 (14.7 kDa) and Scc1-His6 (18.8 kDa).
After the Scc4-Scc1-His6 complex was captured on Ni-IMAC resin and washed with Tris
buffer, 0.5% sarkosyl buffer was used to elute tag-free Scc4 (lane 3) with some Scc1-His6
coeluting. Lane 4 shows the removal of Scc1-His6 from the tag-free Scc4 sample, and lane 5
shows the purified tag-free Scc4 after exchanging the buffer using a P4 gel column. Lane 6
is a Fisher BioReagents EZ-Run Rec prestained protein ladder with the molecular weights
listed to the left in kDa. Lane 7 is Scc1-His6 eluted with imidazole buffer after the elution of
tag-free Scc4. The gel images originated from the same gel; several lanes were removed for
clarity.
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Figure 4.

SDS-PAGE analysis of the expression and purification of the His6-Scc4-Scc1-FT complex.
Lane numbers are labeled along the bottom. Lanes 1 and 2 are samples of the culture before
and after induction with IPTG showing similar levels of His6-Scc4 and Scc1-FT expression.
Lane 3 is the pellet, and lane 4 is the cleared lysate after cell lysis. The complex was purified
using Ni-IMAC resin with the lysate flow-through (lane 5), wash step (lane 6), and elution
of the His6-Scc4-Scc1-FT complex with imidazole buffer (lane 7). Lane 8 is the Bio-Rad
Precision Plus protein standard with the molecular weights listed to the right in kDa. His6Scc4 is 15.8 kDa, and Scc1-FT is 18.2 kDa.
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Figure 5.
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On-column dissociation of His6-Scc4-Scc1-FT. Lane numbers are labeled along the bottom.
Lane 1 is a Fisher BioReagents EZ-Run Rec prestained protein ladder with the molecular
weights listed to the left in kDa. Lane 2 is the purified, desalted His6-Scc4-Scc1-FT that was
captured on Ni-IMAC resin and washed (lane 3) with buffer (His6-Scc4 is 15.8 kDa, and
Scc1-FT is 18.2 kDa). Lane 4 shows the sarkosyl-dissociated Scc1-FT, and lane 5 is His6Scc4 eluted with imidazole buffer. The gel images originated from the same gel; several
lanes were removed for clarity.
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Figure 6.

(A) 1H-15N HSQC spectrum of 0.3 mM His6-Scc4* with 64 scans. (B) An overlay of
1H-15N HSQC spectra of 0.3 mM His -Scc4* (64 scans, blue) and 0.5 mM His -Scc4 (64
6
6
scans, red) with the same buffer and instrument conditions.
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Figure 7.

(A) 1H-15N HSQC spectrum of 0.5 mM tag-free Scc4 with 16 scans. (B) An overlay of
1H-15N HSQC spectra of 0.5 mM tag-free Scc4 (16 scans, blue) and 0.5 mM His -Scc4 (64
6
scans, red) with the same buffer and instrument conditions. (C) 1D projections of the 1H
dimension from the overlaid spectra in panel B.
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